Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pure Global Cannabis Inc PRCNF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Pure Global Cannabis Inc is a growth-oriented life science cannabis company led by experienced pharma-industry, horticultural and supply chain experts.


GREY:PRCNF - Post by User

Pure Global Cannabis Inc > PURE in my view going to 0.07
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(121)
•••
Comment by JMark80on Jun 03, 2019 6:16pm
96 Views
Post# 29795500

RE:RE:RE:RE:PURE in my view going to 0.07

RE:RE:RE:RE:PURE in my view going to 0.07Yes, should hear something soon regarding construction/HC approval. Unfortunately company has ineffectual top heavy management, is nearly broke, and hasn't been able to raise capital. On the plus side, downside from here is very limited.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities